tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports

Arbutus Biopharma (ABUS) Financial Statements

1,272 Followers

Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently $840.56M. The company's EPS TTM is $-0.01; its P/E ratio is -27.51; Arbutus Biopharma is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.08M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Gross Profit$ 13.72M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Operating Income$ -27.05M$ -76.32M$ -78.10M$ -65.46M$ -73.52M
EBITDA$ -26.69M$ -68.40M$ -70.99M$ -61.86M$ -71.64M
Net Income$ -33.50M$ -69.92M$ -72.85M$ -69.46M$ -76.25M
Balance Sheet
Cash & Short-Term Investments$ 91.47M$ 122.62M$ 126.00M$ 146.91M$ 155.32M
Total Assets$ 94.62M$ 131.71M$ 144.40M$ 195.42M$ 204.49M
Total Debt$ 4.19M$ 1.29M$ 8.72M$ 12.55M$ 18.91M
Net Debt$ -13.82M$ -35.04M$ -17.56M$ -18.22M$ -90.37M
Total Liabilities$ 18.04M$ 34.34M$ 38.38M$ 58.57M$ 35.05M
Stockholders' Equity$ 76.58M$ 97.37M$ 106.02M$ 136.85M$ 169.44M
Cash Flow
Free Cash Flow$ -39.64M$ -65.03M$ -86.94M$ -35.87M$ -68.34M
Operating Cash Flow$ -39.64M$ -64.85M$ -85.94M$ -35.36M$ -67.53M
Investing Cash Flow$ 15.58M$ 22.95M$ 50.77M$ -74.94M$ -12.68M
Financing Cash Flow$ 5.72M$ 52.00M$ 30.65M$ 31.81M$ 137.24M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Income Statement >

Arbutus Biopharma Debt to Assets

Balance Sheet >

Arbutus Biopharma Cash Flow

Cash Flow >

Arbutus Biopharma Forecast EPS vs Actual EPS

Earnings >